Cross-sectional study of primary antimicrobial treatment and vaccination coverage in outbreaks of bovine respiratory disease on dairy and beef farms in northern Belgium.

Decision tree analysis for pathogen identification based on circumstantial factors in outbreaks of bovine respiratory disease in calves

Cluster analysis of bovine respiratory disease (BRD)-associated pathogens shows the existence of two epidemiological patterns in BRD outbreaks

We investigated the occurrence of infectious pathogens during an outbreak of bovine respiratory disease (BRD) in a beef cattle feedlot in southern Brazil that has a high risk of developing BRD. Nasopharyngeal swabs were randomly collected from steers ( n = 23) and assessed for the presence of infectious agents of BRD by PCR and/or RT-PCR assays. These included: Histophilus somni, Mannheimia haemolytica, Pasteurella multocida, Mycoplasma bovis, bovine respiratory syncytial virus (BRSV), bovine coronavirus (BCoV), bovine viral diarrhea virus (BVDV), bovine alphaherpesvirus 1 (BoHV-1), and bovine parainfluenza virus 3 (BPIV-3). Pulmonary sections of one steer that died with clinical BRD were submitted for pathology and molecular testing. The frequencies of the pathogens identified from the nasopharyngeal swabs were: H. somni 39% (9 of 23), BRSV 35% (8 of 23), BCoV 22% (5 of 23), and M. haemolytica 13% (3 of 23). PCR or RT-PCR assays did not identify P. multocida, M. bovis, BoHV-1, BVDV, or BPIV-3 from the nasopharyngeal swabs. Single and concomitant associations of infectious agents of BRD were identified. Fibrinous bronchopneumonia was diagnosed in one steer that died; samples were positive for H. somni and M. haemolytica by PCR. H. somni, BRSV, and BCoV are important disease pathogens of BRD in feedlot cattle in Brazil, but H. somni and BCoV are probably under-reported.

In order to obtain data concerning the involvement of Mannheimia haemolytica in bovine respiratory disease (BRD) outbreaks, a serological survey was carried out on paired (acute- convalescent) sera from 1310 beef and 810 dairy cattle collected in 262 BRD outbreaks in Italian herds during 2002-2006. No vaccination program to M. haemolytica A1 was applied in the investigated herds. For each outbreak, 5 to 12 animals were considered for serum sampling. An enzyme linked immunosorbent assay (ELISA) was used to determine serum antibody response to M. haemolytica leukotoxin (LKT). Seroconversion involved 467 animals (22%), 314 beef cattle (24%) and 153 dairy cattle (19%), respectively. On a serological basis, M. haemolytica involvement was detected in 162 (62%) BRD outbreaks. Prevalence of seroconversion ranged from 20% to 60%. Concurrent seroconversion to M. haemolytica and the main bovine respiratory viruses was re- corded in 141 (54%) outbreaks. Seroconversion to M. haemolytica LKT involved mainly cattle not vaccinated to BRD vi- ral agents.

In the veal industry in The Netherlands, each year around 1.2 million “white” veal calves are produced on around 1100 farms. Bovine respiratory disease (BRD) causes serious health issues in these calves, also resulting in high usage of antimicrobials. To reduce antimicrobial usage, a more targeted treatment regime is needed, for which it is necessary to identify the causative agent. This study aimed at determining associations between pathogens and clinical disease, between prevalence of pathogens and BRD outbreaks, and BRD and performance. A cohort study was conducted involving ten veal farms, in which calf respiratory health was evaluated for the first 12 weeks. Whenever there was an outbreak of BRD, as determined by the farm veterinary surgeon, samples were taken from diseased and control calves through broncho-alveolar lavage. From these samples a broad spectrum of micro-organisms were isolated. Performance data were also collected. A total of 23 outbreaks happened during the 12 week study period, mostly in the first six weeks. BRD associated pathogens found were: BHV1, BPI3V, BRSV, BVDV, Pasteurella multocida, Mannheimia haemolytica, Trueperella pyogenes, Histophilus somni, Mycoplasma bovis, Mycoplasma bovirhinis and Mycoplasma dispar. For most BRD associated pathogens, there was no clear association between presence or prevalence of the micro-organisms and clinical issues. Only T. pyogenes (7.4% in healthy, 14.6% in diseased calves, p 0.013), M. bovis (37.6% and 63.2% respectively, p 0.001) and BVDV (9.9% and 16.9% respectively, p 0.03) were found more often in diseased animals. BPI3V was found in a few early outbreaks, which might suggest involvement in early outbreaks. It appears to be difficult to associate specific pathogens to outbreaks at the species level. BRD is the major reason for treatment with antimicrobials. More specific knowledge about the association between pathogens and health/disease could help to reduce antimicrobial use.

Microbial diversity involved in the etiology of a bovine respiratory disease outbreak in a dairy calf rearing unit

Four outbreaks of bovine respiratory disease (BRD) associated with bovine coronavirus (BCoV) infection in Italian cattle herds were reported. In 3 outbreaks, BRD was observed only in 2-3-month-old feedlot calves, whereas in the remaining outbreak, lactating cows, heifers, and calves were simultaneously affected. By using reverse transcription polymerase chain reaction (RT-PCR), BCoV RNA was detected in all outbreaks without evidence of concurrent viral pathogens (i.e., bovine respiratory syncytial virus, bovine herpesvirus type 1, bovine viral diarrhea virus, bovine parainfluenza virus). Common bacteria of cattle were recovered only from 2 outbreaks of BRD: Staphylococcus spp. and Proteus mirabilis (outbreak 1) and Mannheimia haemolytica (outbreak 4). A recently established real-time RT-PCR assay showed that viral RNA loads in nasal secretions ranged between 3.10 x 10(2) and 7.50 x 10(7) RNA copies/microl of template. Bovine coronavirus was isolated from respiratory specimens from all outbreaks except outbreak 1, in which real-time RT-PCR found very low viral titers in nasal swabs.

The mobilisation and impact of roadway runoff on dairy farms has been established as a sub-component of the nutrient transfer continuum. It is acknowledged that fresh nutrient sources deposited on roadways dominate runoff and recent work has shown that available phosphorus (P) in roadway substrates is also an important source component. The objectives of this study were to understand spatial and temporal available P concentrations in roadway substrate (aggregate and soil mix) across dairy and beef farms during the open (February–October, when cows use the roadway network and fields) and closed (November–January, when cows were housed) periods and identify locations which could be considered critical source areas (CSA). For the study, roadway substrate samples were taken at 18 locations on each farm, across eight sampling periods, and were analysed for available P. Results showed that mean available P concentrations (Morgan’s P) in the sampling locations ranged from 15.9 to 101.4 mg L-1 for the Dairy Farm, from 4.1 to 59.4 mg L-1 for Beef Farm 1 and from 6.3 to 23.2 mg L-1 for Beef Farm 2. In open period, the results showed that mean available P concentrations were 75.4 ± 30.9, 14.9 ± 3.2 and 13.4 ± 2.5 mg L-1 for the Dairy Farm, Beef Farm 1 and Beef Farm 2, respectively. In closed period, the mean available P were 40.3 ± 17.2, 10.4 ± 1.0 and 9.8 ± 0.2 mg L-1 for Dairy Farm, Beef Farm 1 and Beef Farm 2, respectively. Overall, P concentrations on the Dairy Farm roadways was up to 4 times greater than that in the Beef Farms’ roadways. Compared to soils in adjacent fields, P concentrations in the Dairy and Beef Farms roadways was up-to 7 and 2 times higher, respectively. Critical roadway sections that required mitigation were two in the Dairy Farm, one in Beef Farm 1 and two in Beef Farm 2. In addition to fresh faeces and urine (i.e., dominant source of nutrients in farm roadways), this study showed that nutrient enriched roadway materials are a labile P source. Thus, future mitigation of roadway runoff must consider all roadway nutrient sources, including livestock fresh excreta as well as used roadway surface materials.

The goal of this study was to determine the clinical and economic impact of using tulathromycin as first line treatment for bovine respiratory disease (BRD) compared with other commonly used antimicrobials. Two decision trees were developed simulating the consequences of treating cattle at high risk of developing BRD [control model (CM)] or cattle with first clinical BRD episode [treatment model (TM)]. As comparators florfenicol and tilmicosin were considered in both models whereas enrofloxacin was included in the TM because it was only labeled for treatment of BRD at the time of development of the calculators. A total of 5 (CM) and 10 (TM) comparative clinical studies that reported efficacy data for the selected drugs and indications were identified as suitable for model population. The following outcomes were considered: first treatment success, number of subsequent BRD treatments, chronics, and mortalities. Cost parameters were considered from the perspective of the producer and included treatment costs (first treatment and retreatments) and costs of chronics and deaths derived from published sources for 2010 (default). The models allowed the estimation of clinical and economic consequences according to each individual trial outcomes. Treatment with tulathromycin resulted in more first treatment successes and fewer removals (chronics and deaths) in all comparisons. The average total number of antimicrobial treatments required for the management of BRD was also least with tulathromycin as first treatment option. Because of better efficacy, total costs over the entire study periods were always lowest with tulathromycin. Depending on the study selected as the basis for the efficacy evaluation, cost savings with tulathromycin were calculated in the CM between US$21.00 and $47.86 (vs. florfenicol) and $11.37 and $72.64 (vs. tilmicosin); cost savings in the TM ranged between $28.47 and $143.87 (vs. florfenicol) and $7.75 and $84.91 (vs. tilmicosin) as well as between $23.22 and $47.82 (vs. enrofloxacin), with the ranges reflecting a variety of settings in different trials. Thus, the higher drug costs of tulathromycin were more than offset by reduced BRD treatments, chronics, and mortalities in the herd. Fewer BRD episodes in cattle treated with tulathromycin not only contributes to overall savings in BRD management but also reduces the necessity of repeated antibiotic treatment, supporting prudent use of antimicrobials in livestock.

A voluntary control programme for Johne’s disease, the Irish Johne’s Control Programme (IJCP) has been implemented in Ireland since 2017. The objective of this observational study was to assess Irish beef and dairy farmers’ Johne’s disease knowledge, implemented management practices and IJCP opinions. A questionnaire open to dairy and beef farmers was distributed via social media and email. In total 126 responses were used for this study; these responses came from mostly young farmers (18–25 years old) and represent a small proportion of the total number of dairy and beef farmers in Ireland whose average age is 55.Most respondents claimed to know what Johne’s disease was (73%; 92/126) and associated the disease to loss of body condition (68%; 78/114) and diarrhoea (59%; 67/114). Twenty-eight respondents (mostly dairy farmers; 22/28) reported positive cases in their premises. And 38% reported to implement management practices to prevent Johne’s disease transmission within or into their herd (i.e. management of milk for calf consumption and isolation of Johne’s test-positive or newly purchased stock; 47/124).Eighteen percent (22/125) of respondents were, at the time of questionnaire or previously, members of the IJCP. The main benefits reported by some of the participating farmers were identification of positive cases (29%; 4/14), and management of milk for calf consumption (21%; 3/14). While the main disadvantage was inaccurate testing methods (50%; 10/20). The main reasons reported for the lack of participation in the IJCP were not being aware of the programme (52%; 53/102) and not having a Johne’s disease problem on the farm (48%; 49/102).In conclusion, this study suggests that while young farmers are aware of Johne’s disease, their participation in the IJCP is limited and could benefit from further promotion. Studies representing the wider farming community in Ireland are warranted to gather non-biased input and contribute to Johne’s disease control in Ireland.

Mycoplasma bovis is an important cause of bovine respiratory disease (BRD) in newly received cattle at fattening operations. However, little information on its within-pen transmission dynamics during a BRD outbreak is available. Such information is nevertheless crucial to adapt control measures during M. bovis-associated BRD outbreaks. The objective of the current study was to determine whether single or multiple clones of M. bovis are present within a pen during a BRD outbreak that occurs early in the feeding period. Sixteen BRD outbreaks that naturally occurred in 12 pens of 8-12 bulls each (n = 112) newly received at 3 fattening operations were investigated. Two hundred and thirty-nine transtracheal aspirations (TTA) were performed during the outbreaks, and the M. bovis isolates obtained were characterized by pulsed-field gel electrophoresis (PFGE). Mycoplasma bovis isolates were recovered from TTA in 8 of the 16 BRD outbreaks that occurred. The within-pen prevalence of bulls positive for M. bovis during these outbreaks ranged from 8% to 100%. The PFGE analysis revealed that, even though bulls came from multiple origins, a single clone of M. bovis was present within a pen during BRD outbreaks with a high prevalence of M. bovis infection. The study therefore indicates that, even if M. bovis can recrudesce from carriers after stressful events such as transportation and commingling, the increased prevalence of M. bovis pulmonary infection observed during BRD outbreaks that are early occurring in the feeding period seems primarily due to the horizontal transmission of only 1 clone among cattle.

HoBi-like pestivirus infection in an outbreak of bovine respiratory disease

Acute phase protein changes in calves during an outbreak of respiratory disease caused by bovine respiratory syncytial virus

To investigate the association of bovine respiratory disease (BRD) or vaccination with serologic response in calves. 94 Holstein calves. To assess the association between BRD and antibody titers, 38 calves < 3 months old that were treated for BRD were matched with 38 untreated calves. To investigate the effect of vaccination on antibody titers, 24 calves were randomly assigned to be vaccinated against bovine respiratory syncytial virus (BRSV), bovine viral diarrhea virus types 1 and 2, bovine herpesvirus type 1 (BHV1), and parainfluenza virus type 3 at 2 weeks of age (n = 6), 5 weeks of age (6), and both 2 and 5 weeks of age (6) or were assigned to be unvaccinated controls (6). Blood samples were obtained at I, 2, 5, and 12 weeks for determination of serum neutralization antibody titers against the vaccine viruses, bovine coronavirus, and Mannheimia haemolytica. Antibody rates of decay were calculated. Calves with initial antibody titers against BRSV < 1:64 that were treated for BRD had a slower rate of anti-BRSV antibody decay than did similar calves that were not treated for BRD. Calves with high initial antibody titers against BRSV and BHV1 had lower odds of BRD than did calves with low initial antibody titers against those 2 pathogens. Vaccination at 2 or 5 weeks of age had no effect on the rate of antibody decay. Clinical BRD and the serologic response of dairy calves were associated with initial antibody titers against BRSV and BHV1. Serologic or clinical responses to viral exposure may differ in calves with low passive immunity.

Mycoplasma bovis is a key pathogen in the bovine respiratory disease complex, known for causing significant health issues in cattle. A dairy farm in Scotland faced a significant outbreak of bovine respiratory disease in pre‐weaning calves (0–60 days old) during the winter period. M. bovis was identified as the primary pathogen in this case due to historical, clinical and postmortem evidence. The farm's calf management practices were found lacking, notably in the use of pooled colostrum, waste milk and incorrectly prepared milk replacer. A biocontainment strategy was implemented, focusing on isolating affected calves and revising feeding and cleanliness practices. After 3 months, the morbidity rate decreased to 3%, and there were no dead calves due to bovine respiratory disease. These evidence‐based interventions proved effective in containing the M. bovis outbreak, highlighting the critical role of proactive management and prompt response in controlling the disease.